About

Carbon Recycling Technology for the Future

LanzaTech’s carbon recycling technology is like retrofitting a brewery onto an emission source like a steel mill or a landfill site, but instead of using sugars and yeast to make beer, pollution is converted by bacteria to fuels and chemicals! Imagine a day when your plane is powered by recycled GHG emissions, when your shampoo bottle started life as emissions from a steel mill. This future is possible today using LanzaTech technology.

A fifteen-year journey

2022

3rd Commercial Plant comes online in China

Carbon Negative Chemical Production Announced

Announcement to go public through a business combination with AMCI Acquisition Corp. II.

Direct MEG Production Demonstrated

Waste-to-ethanol facility in Japan with Sekisui starts up

2021

2nd Commercial plant online in China

Unilever detergents made with CarbonSmart™ ethanol on sale in Germany, China and South Africa

Coty partnership announced to use CarbonSmart™ ethanol in most of fragrance production from 2023

First ZARA collection launched made using polyester fabric produced from CarbonSmart™ ethanol.

Synthetic biology partnership with German chemicals giant BASF for production of specialty chemical. n-octanol.

Partnership to make EVA foam for running shoes with On and Borealis.

LanzaTech granted over 1,000 patents

2020

CarbonSmart™ ethanol sold in stores in Switzerland in Migros Potz general cleaner thanks to partnership with Mibelle.

Partnership with L'Oréal and Total Energies to make polyethylene for packaging.

Over 20M gallons of ethanol produced at first commercial facility in China, the equivalent of preventing 100,000 tons of CO2 from hitting the atmosphere.

LanzaJet is founded to accelerate the commercialization of sustainable aviation fuel technology.

2019

Novo Holdings invests in LanzaTech

ANA signs offtake agreement for SAF

ANA's Latest Jet Delivered from Boeing using a blend of drop in jet fuel produced from steel mill emissions.

First production of PET with India Glycols Limited and Far Eastern New Century (FENC)

2018

First Commercial Scale facility begins operations in China converting steel mill emissions to ethanol.

ASTM International added ethanol as an approved feedstock for Aviation Turbine Fuel Containing Synthesized Hydrocarbons for alcohol-to-jet synthetic paraffinic kerosene (ATJ-SPK)

Virgin Atlantic used sustainable aviation fuel (SAF) made by LanzaTech on a commercial flight from Orlando, Florida to London Gatwick in October 2018, using a blend of drop in jet fuel produced from steel mill emissions.

2017

Positive results from First MSW to Ethanol plant in Japan

Indian Oil Corporation Limited announce statement of intent with LanzaTech to construct world first refinery gas to ethanol plant.

DOE grant to support collaborative work on microfluidics with Berkeley Lab, SNL and JBEI, creating faster and most cost-effective synthetic biology research

DOE grant with Northwestern University and ORNL to establish the Clostridia Foundry for Biosystems Design (cBioFAB) center, enabling the shift from a large-scale laboratory to a mini air free lab, the size of an office desk and access virtually any molecule, even those not produced in nature

1,500 US gallons of jet fuel has been produced from ‘Lanzanol’ ethanol.

2016

LanzaTech Awarded $4M from DOE for Low Carbon Jet & Diesel Demonstration Facility

LanzaTech Wins Major Circular Economy Award at the World Economic Forum Annual Meeting

ArcelorMittal, LanzaTech and Primetals Technologies announce partnership to construct breakthrough €87m Facility in Belgium

2015

Team wins EPA Presidential Green Chemistry Award

LanzaTech and the  IOC-DBT Center for Advanced Bio-Energy Research (an entity co-funded by India’s Department of Biotechnology and Indian Oil Corporation Limited) develop process that recycles CO2 into omega-3 rich fatty acids.

2014

NZ Super Fund invests in LanzaTech

LanzaTech moves Head Quarters and Lab Facilities from Auckland, NZ to Skokie, IL.

Mitsui Leads Investment in LanzaTech’s $60M Series D Round

Board of Directors

Dr. Mahpuzah Abai

Dr. Mahpuzah Abai

Dr. Abai has 25 years experience in the Oil & Gas industry, managing & leading technology and commercialization projects. She has pioneered the development and commercialization of new chemistries for PETRONAS applications. She previously led the Fluid Technology Solutions team which provides world-class fluids for PETRONAS lubricants, fuels, and motorsports.
CEO, PETRONAS Technology Ventures Sdn Bhd; Head of Technology Management & Commercialisation, PETRONAS

Nigel Gormly

Nigel Gormly brings a wealth of investment experience focused on climate solutions and large-scale growth companies, including from the New Zealand Super Fund where he previously led the International Direct Investment team. He has broad governance experience across a range of sectors and stages of development and currently serves as a director for View, Inc. and CTF Pledge Pioneers. Nigel has served as a Director for LanzaTech since 2014 and has chaired the Audit Committee since 2015.
Director, Waihou Capital, Rep. NZ Super Fund

Dr. Jennifer Holmgren

Prior to LanzaTech, Jennifer founded and led, as VP/GM, UOP’s (Honeywell) Renewable Energy and Chemicals Division. She has over 30 years of commercialization experience.
CEO, LanzaTech

Jim Messina

Jim Messina is the CEO of the Messina Group, which provides strategic consulting to political campaigns, advocacy organizations and businesses. He was also Campaign Manager of Barack Obama’s 2012 re-election campaign and Deputy Chief of Staff to President Obama.
CEO, The Messina Group

Dr. SSV Ramakumar

Dr. Ramakumar has three decades of R&D experience in the downstream hydrocarbon sector specifically in the areas of lubricant technology and refinery process research, including catalyst development and alternative sources of energy. He successfully spearheaded many “concept to commercialization” projects and is overseeing the establishment of one of the world’s largest renewable energy research campuses. He has to his credit 50 granted patents and around 150 research publications in peer reviewed journals.
Director R&D, Indian Oil Company

Bo Ren

Bo Ren is managing director of the Industrial Investment Department at Sinopec Capital, with extensive experience in renewable energy, green chemicals, bio-materials, advanced manufacturing investment business. Prior to joining Sinopec Capital, he worked at CITIC SECURITIES as director of the Investment Banking Committee after graduating from Tianjin University.
Managing Director, Sinopec Capital

Gary Rieschel

Gary founded several venture capital firms including SoftBank Venture Capital, SAIF Partners, and Qiming Venture Partners. Qiming now has $7b under management.
Founder and Managing Partner, Qiming

Dr. Sean Simpson

Sean held research scientist roles at AgriGenesis (NZ) and Japan International Research Centre for Agricultural Sciences (Tsukuba, Japan), prior to founding LanzaTech in 2005.
Founder and CSO, LanzaTech

Dr. Anders Spohr

Anders is responsible for bio-industrial investments at Novo Holdings. Prior to joining Novo Holdings, he previously held executive positions at Leo-Pharma and Novozymes.
Senior Partner, Principal Investments, Novo Holdings

Yasuhiro Uchida

Yasuhiro is the general manager of Mitsui’s NexGen Energy Division. He has had extensive industry experience in the Energy business, especially in the oil & gas investment business, such as E&P and LNG. He began his career in Mitsui & Co., Ltd. in 1994 shortly after graduating from Tokyo University (Mineral Development Engineering).
General Manager, Mitsui

Dr. Roger Wyse

Dr. Wyse is Co-Founder & Managing Partner at Spruce Capital Partners, a venture management company with $320 million in AUM investing in companies with disruptive solutions to improve sustainability, enable the bioeconomy and mitigate climate change. Previously, he was President and COO Biogreentech at Burrill & Company. Before his venture career he was a renowned scientist and academic administrator serving as Dean, College of Agriculture & Life Sciences, UW Madison.
Managing Partner, Spruce Capital

Scientific Advisory Board

Prof. Dr. Michael Jewett

Dr. Jewett is the Charles Deering McCormick Professor of Teaching Excellence, Walter P. Murphy Professor of Chemical and Biological Engineering, and director of the Center for Synthetic Biology at Northwestern University. He is also an Institute Fellow at the Northwestern Argonne Institute for Science & Engineering. Dr. Jewett’s lab seeks to re-conceptualize the way we engineer complex biological systems for compelling applications in medicine, materials, and energy by transforming biochemical engineering with synthetic biology.

Prof. Dr. Ramon Gonzalez

Dr. Gonzalez is a Professor and Florida World Class Scholar in the Department of Chemical, Biological and Materials Engineering at the University of South Florida (USF) where he leads the laboratory for Metabolic Engineering and Biomanufacturing. He is also the Editor-in-Chief of the Journal of Industrial Microbiology and Biotechnology (JIMB). Before joining USF, Dr. Gonzalez was a Professor in the Departments of Chemical & Biomolecular Engineering and Bioengineering at Rice University and the Founding Director of Rice’s Advanced Biomanufacturing Initiative, and from 2012 to 2015 served as Program Director with the Advanced Research Projects Agency-Energy (ARPA-E) of the U.S. Department of Energy.

Prof. Dr. Huimin Zhao

Dr. Zhao is the Steven L. Miller Chair Professor of chemical and biomolecular engineering, and professor of chemistry, biochemistry, biophysics, and bioengineering at the University of Illinois at Urbana-Champaign (UIUC). He received his B.S. degree in Biology from the University of Science and Technology of China in 1992 and his Ph.D. degree in Chemistry from the California Institute of Technology in 1998 under the guidance of Nobel Laureate Dr. Frances Arnold. Prior to joining UIUC in 2000, he was a project leader at the Industrial Biotechnology Laboratory of the Dow Chemical Company. He was promoted to full professor in 2008. Dr. Zhao has authored and co-authored over 340 research articles and over 30 issued and pending patent applications with several being licensed by industry.

Prof. Dr.-Ing. Ralf Takors

Dr. Takors is heading the Institute of Biochemical Engineering (IBVT) at the University of Stuttgart. Main research interests are systems metabolic engineering, synthetic biology and biochemical engineering to develop novel bioprocesses from lab to productions cale. Wet-lab activities are supported by intensive modelling activities comprising genome scale stochiometric modelling, metabolic flux analysis, gene regulatory networks, and bioreactor modelling using compartmented approaches and computational fluid dynamics.

Prof. Dr. Rolf Thauer

Dr. Thauer is the Emeritus group leader at the Max Planck Institute for Terrestrial Microbiology for which he was one of the founding directors in 1991. Author of over 400 publications and the recipient of numerous awards, including the Gottfried Wilhelm Leibniz Prize by the Deutsche Forschungsgemeinschaft in 1987. He holds a Ph.D. degree in biochemistry from the University of Freiburg, Germany. He has more than 50 years of research experience in biochemistry, physiology and ecology of anaerobic bacteria and archaea with a focus on the enzymes and coenzymes involved in the energy metabolism of Clostridia.